These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29436617)

  • 1. RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.
    Qi ZH; Xu HX; Zhang SR; Xu JZ; Li S; Gao HL; Jin W; Wang WQ; Wu CT; Ni QX; Yu XJ; Liu L
    Int J Oncol; 2018 Apr; 52(4):1105-1116. PubMed ID: 29436617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.
    Gao Y; Hou J; Fei X; Ren L; Lu R; Liu P; Liu S; Zhu C; Wang X; Pan Y
    Cell Signal; 2024 Aug; 120():111227. PubMed ID: 38744388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-Lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells.
    Zhao J; O'Donnell VB; Balzar S; St Croix CM; Trudeau JB; Wenzel SE
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14246-51. PubMed ID: 21831839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells.
    Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K
    Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of multidrug resistance by gefitinib via RAF1/ERK pathway in pancreatic cancer cell line.
    Xiao Z; Ding N; Xiao G; Wang S; Wu Y; Tang L
    Anat Rec (Hoboken); 2012 Dec; 295(12):2122-8. PubMed ID: 22907845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.
    Klingauf M; Beck M; Berge U; Turgay Y; Heinzer S; Horvath P; Kroschewski R
    Biol Cell; 2013 Feb; 105(2):91-107. PubMed ID: 23157514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑202 inhibits endometrial stromal cell migration and invasion by suppressing the K‑Ras/Raf1/MEK/ERK signaling pathway.
    Zhang D; Wang L; Guo HL; Zhang ZW; Wang C; Chian RC; Zhang ZF
    Int J Mol Med; 2020 Dec; 46(6):2078-2088. PubMed ID: 33125090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human myoblast differentiation by PEBP4.
    Garcia R; Grindlay J; Rath O; Fee F; Kolch W
    EMBO Rep; 2009 Mar; 10(3):278-84. PubMed ID: 19197339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells.
    Noser JA; Mael AA; Sakuma R; Ohmine S; Marcato P; Lee PW; Ikeda Y
    Mol Ther; 2007 Aug; 15(8):1531-6. PubMed ID: 17505473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pranlukast, a novel binding ligand of human Raf1 kinase inhibitory protein.
    Sun T; Wu Z; Luo M; Lin D; Guo C
    Biotechnol Lett; 2016 Aug; 38(8):1375-80. PubMed ID: 27146207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
    Anders M; Christian C; McMahon M; McCormick F; Korn WM
    Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S; Lunn JA; Santiskulvong C; Rozengurt E
    Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.
    Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T
    Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alphaA- and alphaB-crystallins prevent UVA-induced apoptosis through regulation of PKCalpha, RAF/MEK/ERK and AKT signaling pathways.
    Liu JP; Schlosser R; Ma WY; Dong Z; Feng H; Liu L; Huang XQ; Liu Y; Li DW
    Exp Eye Res; 2004 Sep; 79(3):393-403. PubMed ID: 15336502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
    Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
    Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve growth factor regulates CD133 function to promote tumor cell migration and invasion via activating ERK1/2 signaling in pancreatic cancer.
    Xin B; He X; Wang J; Cai J; Wei W; Zhang T; Shen X
    Pancreatology; 2016; 16(6):1005-1014. PubMed ID: 27654574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.